π¨ Medical Ethics - #MedTwitter π¨
#Access2Antivirals is poor. We have heard from NHS sources that only 10-16% of the tiny subset of immunosuppressed people who qualify for treatment receive them within 5 days.
This, in itself, is a serious concern. But not the focus today.
1/
#Access2Antivirals is poor. We have heard from NHS sources that only 10-16% of the tiny subset of immunosuppressed people who qualify for treatment receive them within 5 days.
This, in itself, is a serious concern. But not the focus today.
1/
People are being sent the above email when they *do* qualify for treatment directly from the Covid Medicines Delivery Units (CMDUs).
The Panoramic trial has 450 spaces/day and only 225 doses of Paxlovid (a proven treatment) it is open to Clinically Vulnerable people and 50+.
2/
The Panoramic trial has 450 spaces/day and only 225 doses of Paxlovid (a proven treatment) it is open to Clinically Vulnerable people and 50+.
2/
The Panoramic trial is often heavily oversubscribed especially during times of great need. Whether we need a trial for a treatments proven effective is another question....
The question is:
Is it ethical to prompt someone who qualifies for treatment to apply to this trial?
3/
The question is:
Is it ethical to prompt someone who qualifies for treatment to apply to this trial?
3/
If a person who qualifies for treatment based on their significant medical need applies for the trial, they are taking a gamble. Someone else, who could also be treated on the trial, will be denied.
/END
/END
β’ β’ β’
Missing some Tweet in this thread? You can try to
force a refresh
γ
![[House of Commons letterhead] 17 May 2022 Dear I refer to](https://pbs.twimg.com/media/FTnVsWcWIAASPfT.jpg)
![16 May 2022 Dear Jake, Thank you [...]. Immunocompromised](https://pbs.twimg.com/media/FTnVsk4WAAcAVNF.jpg)
